Search

Search Constraints

You searched for: Author/Creator Panera, N.

Search Results

4. Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers. (February 2019)